↑upin humans3↑upin human cells1↔no changein humans1
5 studies
Metformin increases telomere length in humans (compared with placebo) (+0.247 ± 0.298 vs +0.036 ± 0.068; 29.6% vs 4.4% elongation; between-group p < 0.0001).
“Metformin significantly increased LTL compared to placebo”
Human trialcompared with placeboperipheral blood mononuclear cells500 mg twice daily24 weeksn = 127
Smoking is linked with lower telomere length in men with asthma (adjusted conditional-median ratio 0.38, 95% CI 0.22-0.67).
“light smoking among participants with asthma was associated with lower RTL (adjusted conditional-median ratio 0.38, 95% bootstrap CI 0.22-0.67; p=0.001)”
Physical activity is linked with higher telomere length in humans (2.25% increase (95% CI: 0.01, 4.48; p = 0.04)).
“Children in the highest tertile of extracurricular PA (11.9-31.0 METs h/day) showed a significant 2.25% increase (95% CI: 0.01, 4.48; p = 0.04) in TL ranking”
Nucleotides increase telomere length in the Low-PRS group (β = 0.31, 95% CI 0.10 to 0.53).
“In the Low‐PRS group, NTs supplementation significantly attenuated telomere shortening compared with the control (β = 0.31, 95% CI 0.10 to 0.53, p = 0.0043; Figure ).”
Nucleotides showed no clear effect on telomere length in humans (β = 0.11 (95% CI: −0.06 to 0.28, p = 0.19)).
“In contrast, no significant between‐group difference was observed in LTL (T/S ratio) change over time, with a mean difference of β = 0.11 (95% CI: −0.06 to 0.28, p = 0.19 for Model 1, p = 0.20 for Model 2, and p = 0.19 for Model 3), indicating that the NTs did not have a noticeable effect on telomere length across all models”
Nucleotides showed no clear effect on telomere length in humans (week 19: β = 0.12, 95% CI: -0.05 to 0.28, P = 0.18).
“no significant difference changes of leukocyte telomere length are showed between groups (week 11: β = 0.09, 95% CI: -0.10 to 0.29, P = 0.36; week 19: β = 0.12, 95% CI: -0.05 to 0.28, P = 0.18)”
Cholecalciferol increases telomere length in humans (versus placebo, over 78 weeks) (+14.5% from baseline at week 78).
“LTL increased significantly in the intervention group by week 52 (P = .004) and became more pronounced at week 78 (P = .001), representing a 14.5% increase from baseline.”
Human trialversus placebo, over 78 weeksleukocytes78 weeksfemales
Cholecalciferol increases telomere length in humans.
“These improvements became more pronounced at week 78, with vitamin D group showing significantly greater LTL than placebo (PP: P =.001, ITT: P =.0001), representing a 14.5% increase from baseline.”
Cholecalciferol increases telomere length in humans (Selected clinical studies and meta-analyses; heterogeneous study designs and populations).
“to potentially enhance cognitive function, decrease amyloid β biomarkers, and prolong telomere length, although heterogeneity remains across study designs and populations.”
ReviewSelected clinical studies and meta-analyses; heterogeneous study designs and populations
Arachis hypogaea increases telomere length in humans (skin-roasted peanuts vs control butter) (0.53 (95% CI: 0.01, 1.05)).
“The SRP group showed a significant increase in TL over time compared to the CB group (adjusted mean difference: 0.53; 95% CI: 0.01, 1.05; p-value = 0.048), after adjusting for sex, age, BMI, physical activity, and energy intake.”
Human trialskin-roasted peanuts vs control butterskin-roasted peanuts6 monthsn = 58
Arachis hypogaea showed no clear effect on telomere length in humans (healthy individuals; compared with control butter based on peanut oil) (Mean difference 0.12, 95% CI -0.42–0.66; p = 0.66).
“No significant difference was observed between PB and CB groups (mean difference: 0.12; 95% CI: -0.42, 0.66; p-value = 0.66).”
Human trialhealthy individuals; compared with control butter based on peanut oilpeanut butter32 g/day6 months
Arachis hypogaea increases telomere length in humans (healthy individuals; compared with control butter based on peanut oil) (Mean difference 0.53, 95% CI 0.01–1.05; p = 0.048).
“significant between-group differences in TL changes, particularly between the SRP and CB groups over 6 months (mean difference: 0.53; 95% CI: 0.01, 1.05; p-value = 0.048).”
Human trialhealthy individuals; compared with control butter based on peanut oilskin-roasted peanuts25 g/day6 months
Pythagorean self-awareness intervention increases telomere length in humans (1.49 ± 0.39 to 2.03 ± 0.54, Cohen’s d = 1.53).
“Leukocyte telomere length increased significantly from 1.49 ± 0.39 to 2.03 ± 0.54 (p < 0.001), corresponding to a large effect size (Cohen’s d = 1.53).”
Integrated stress response reduction intervention increases telomere length in humans (post-intervention between-group comparison; longitudinal effect not significant (p=.263)) (between-group p=.002; p=.047 after covariate adjustment).
“a significant between-group difference in LTL was observed post-intervention (p =.002), and this difference remained significant after controlling for covariates (p =.047)”
Human trialpost-intervention between-group comparison; longitudinal effect not significant (p=.263)leukocytes12 weeks
Ramadan fasting showed no clear effect on telomere length in humans.
“Nevertheless, the Wilcoxon test results show that there is no significant statistical difference in rLTL levels before and after fasting (p = 0.112).”
Journal of the ASEAN Federation of Endocrine Societies·
Ramadan fasting showed no clear effect on telomere length in humans (type 2 diabetes mellitus) (0.391 [0.021-1.515] vs 1.117 [0.528-1.741], p = 0.112).
“The relative rLTL in subjects with T2DM was comparable between before and after at least 14 days of Ramadan fasting. (0.391 [0.021-1.515] vs 1.117 [0.528-1.741], p = 0.112).”
Human trialtype 2 diabetes mellitusleukocyteat least 14 daysn = 48
↔no changein cattle1↔no changein silico1↑upin L. agilis1↔no changein R. chinensis1
4 studies
Telomere length showed no clear effect on lifespan in silico (0.17 years, 95% CI -0.54 to 0.88).
“There was no evidence that telomere length was associated with lifespan in men (0.17 years per standard deviation of log telomere length, 95% confidence interval (CI) -0.54 to 0.88”
Spinal stenosis, spondylosis, disc degeneration, spondylolisthesis, or disc prolapse
↔no changein humans1
1 study
Telomere length was not clearly linked with spinal stenosis, spondylosis, disc degeneration, spondylolisthesis, or disc prolapse in humans (Genetically proxied telomere length in two-sample Mendelian randomization).
“We found no evidence that genetically proxied TL was associated with spinal stenosis, spondylosis, disc degeneration, spondylolisthesis, or disc prolapse (all p>0.32).”
HumansGenetically proxied telomere length in two-sample Mendelian randomizationleukocyte
Non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio
→mediatesin humans1
1 study
Telomere length is linked with non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio in humans (16.51% of the noise-level association and 34.90% of the cumulative-noise-exposure association).
“LTL explained the associations of noise level and CNE with NHHR, with the proportions of 16.51% and 34.90%, respectively.”
HumansStatistical mediation of associations of occupational noise level and cumulative noise exposure with NHHRn = 765
Telomere length is linked with depressive symptoms in humans (adult offspring).
“accelerated telomere shortening as a partial mediator reflecting cumulative aging that partially explains the link between MSDP and specific adverse outcomes in adult offspring, particularly hippocampal atrophy, declines in fluid intelligence, and increased depressive symptoms.”
Telomere length is linked with fluid intelligence in humans (adult offspring).
“shortened LTL partially mediated the association between MSDP and atrophy in 11 IDPs-particularly in the hippocampus and its subregions-as well as reduced fluid intelligence performance”
Age is linked with lower telomere length in humans (B = -2.055 kb, p < 0.001).
“multivariable analysis identified only age group as a significant predictor (B = -2.055 kb for nurses aged ≥30 years compared to those <30 years, p < 0.001).”
Progeria showed no clear effect on telomere length in silico (Hutchinson-Gilford Progeria Syndrome).
“conversely to Hutchinson-Gilford Progeria Syndrome, Cerebroretinal Microangiopathy with Calcifications and Cysts, Wiedemann-Rautenstrauch Syndrome, and atypical Werner Syndrome”
Body mass index is linked with lower telomere length in humans (-3.532 bp per 1-unit increase in BMI (95% CI: -6.225 to -1.178; P = 0.002)).
“BMI was significantly and inversely associated with LTL, with a total effect of -3.532 base pairs (bp) per 1-unit increase in BMI (95% confidence interval [CI]: -6.225 to -1.178; P = 0.002).”
Body mass index decreases telomere length in silico (Mendelian randomization) (B=-0.04, P < 0.0001).
“The results showed a negative causal relationship between BMI (B=-0.04, P < 0.0001), BFP (B=-0.06, P < 0.0001) and LTL without being impacted by lipid profiles and T2D.”
Obesity is linked with lower telomere length in patients with severe obesity compared with healthy controls.
“Both subgroups of patients with obesity presented elevated levels of IL-6 and CRP, shorter TLs, lower outcomes in executive functioning tests, and greater metabolic age than healthy subjects.”
Humansin patients with severe obesity compared with healthy controls
↓downin human cells1↓downin humans1−76% proliferative cells
2 studies
Cellular senescence decreases telomere length in humans (progression of T-cell differentiation and senescence).
“Validation in PBMCs from older adults demonstrated the method's ability to detect expected RTL decreases with T-cell differentiation and senescence progression”
Reviewprogression of T-cell differentiation and senescencePBMCs
Cellular senescence decreases telomere length in human cells (76% of proliferative cells).
“in senescent NHBE cells, telomerase activity, TERT mRNA levels, and telomere length were 60%, 2.7%, and 76% of those in proliferative cells, respectively”
Telomere length is associated with mortality in humans (TwinGene; per 1-SD increase in leukocyte telomere length) (HR 0.96, 95% CI 0.93–0.99 per 1-SD increase).
“TL HRs were 0.96 (95% CI: 0.93–0.99) and 0.94 (0.92–0.95), respectively.”
HumansTwinGene; per 1-SD increase in leukocyte telomere lengthn = 9,617
Telomere length predicts mortality in humans (HR 1.10, 95% CI 1.02-1.19).
“Shorter age-adjusted LTL was associated with increased mortality risk in univariable analysis (HR per 1 SD decrease = 1.10, 95% CI 1.02-1.19; p = 0.012).”
Telomere length is linked with a lower risk of mortality in humans (chronic kidney disease).
“Longer LTL associated with the lower risk of all-cause mortality, cardiovascular disease (CVD) and cancer-related mortality, and U-shaped relationships were detected.”
Telomere length is linked with a lower risk of mortality in humans (hypertension) (-25% risk (Q4 vs Q1)).
“Participants in the highest TL quartile (Q4) for DNAmTL and qPCRTL had a 36% and 25% reduced risk of all-cause mortality than those in the lowest quartile (Q1), respectively.”
Humanshypertensionmedian follow-up of 184 monthsn = 1,601
Telomere length is associated with mortality in humans (Shorter leukocyte telomere length) (HR 1.13, 95% CI 1.09–1.18).
“a coronary artery calcium score above zero, a low ankle-brachial index and shorter leucocyte telomere length are associated with both mortality outcomes.”
American Journal of Respiratory and Critical Care Medicine·
All 11Fewer
Age
↓downin humans7↓downin C. gigas1↓downin dogs1
9 studies
Age is associated with telomere length in humans (sickle cell disease) (r = -0.414; adjusted β = -0.022 per year; more than 50% decrease between childhood and young adulthood).
“aLTL showed a moderate inverse correlation with age ( r = -0.414; r2:0.17; p-value < 2e-16) with no significant differences among SCD genotypes.”
High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension·
Metabolic syndrome is associated with telomere length in humans (Patients without cardiovascular diseases; metabolic syndrome versus comparison group) (7.36 (6.96 - 8.67) pn versus 8.72 (8.37 - 8.96) pn; P = 0.016).
“The median telomere length in MS patients (7.36 (6.96 - 8.67) pn) was significantly lower than in the comparison group”
HumansPatients without cardiovascular diseases; metabolic syndrome versus comparison groupleukocyten = 45
Telomere length is associated with metabolic syndrome in humans.
“there is a positive correlation between the development of metabolic syndrome and its components, including oxidative stress as a key pathogenic factor, and changes in the length of chromosome telomeres”
Telomere length is associated with cognitive function in humans after full adjustment; T3 vs T1 tertiles (T3 vs T1: β = 2.5, 95% CI 0.69–4.3; T2 vs T1: β = 2.1).
“longer telomere length was positively associated with higher digit symbol substitution test scores after full adjustment”
Telomere length is associated with cognitive function in humans.
“Nested multivariable regression models revealed preliminary evidence for associations between telomere length and cognitive performance, and these associations were partially independent of chronological age.”
Telomere length is associated with cognitive function in humans.
“Shorter leukocyte telomere length (LTL) is associated with increased risk and severity of stroke, poorer cognitive outcomes in AD, and increased neuroinflammation in MS”
Telomere length is linked with a lower risk of chronic kidney disease in humans (fully adjusted model, Q4 vs Q1) (OR = 0.445, p = 0.004).
“longer LTL was inversely associated with CKD risk across quartiles: Q2 (OR = 0.681, p = 0.047), Q3 (OR = 0.567, p = 0.015), and Q4 (OR = 0.445, p = 0.004).”
Psychological stress is associated with telomere length in humans (breast cancer survivors).
“accelerated ageing (shortened telomeres) in survivors was primarily associated with impaired functional status, excessive sleep, high stress, radiotherapy, and high processed meat consumption.”
Sleep duration is associated with telomere length in humans (breast cancer survivors).
“accelerated ageing (shortened telomeres) in survivors was primarily associated with impaired functional status, excessive sleep, high stress, radiotherapy, and high processed meat consumption.”
Humansbreast cancer survivorsexcessivefemalesn = 262
Trained immunity non-response is associated with telomere length.
“TL change 3 months after vaccination differed significantly for male non-responders and responders, telomere loss being more pronounced in non-responders ( E).”
Panax ginseng is associated with telomere length in humans (high-dose (6 g/day) and low-dose (3 g/day) cohorts).
“The high-dose and low-dose groups showed a significant association with increased telomere length, POT1 expression, NAD+/NADH ratio, and NAMPT activity.”
Human trialhigh-dose (6 g/day) and low-dose (3 g/day) cohortsleukocytes
At any given time, chicks whose parents received a stress hormone faced nearly twice the risk of dying as chicks whose parents received a placebo.At any given time, chicks whose parents received a stress hormone faced nearly twice the risk of dying as chicks whose parents received a placebo.